Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

November 12, 2009

NEP, Canadian Institute To Develop Cancer Treatments

New England Peptide of Gardner and the Atlantic Cancer Research Institute of New Brunswick, Canada, have formed a partnership to develop cancer-related peptide reagents.

Peptides that bind strongly to cancer-related proteins could have multiple research applications for a wide range of cell types and human tissues, the nonprofit ACRI said.

New England Peptide, which produces custom peptides used in scientific research, said the reagents developed by the partnership have potential to be used in cancer diagnostics and treatments.

"The materials are still in the testing phase, but we anticipate that our research partnership will culminate in a series of commercial products," NEP said.

Financial terms of the partnership were not disclosed.

Sign up for Enews

WBJ Web Partners

0 Comments

Register for free to read more articles.

Register Now

Already have an online account? Login

To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy

Allow Cookies